Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry.
Jolly SS, Lee SF, Mian R, Kedev S, Lavi S, Moreno R, Montalescot G, Hillani A, Henry TD, Asani V, Storey RF, Silvain J, Spratt JCS, d'Entremont MA, Stankovic G, Zafirovska B, Natarajan MK, Sabate M, Shreenivas S, Pinilla-Echeverri N, Sheth T, Altisent OA, Ribas N, Skuriat E, Tyrwhitt J, Mehta SR. Jolly SS, et al. Among authors: silvain j. Am J Cardiol. 2024 Jun 1;220:111-117. doi: 10.1016/j.amjcard.2024.02.021. Epub 2024 Mar 4. Am J Cardiol. 2024. PMID: 38447893 Free article. Clinical Trial.
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
Collet JP, Silvain J, Landivier A, Tanguy ML, Cayla G, Bellemain A, Vignolles N, Gallier S, Beygui F, Pena A, Montalescot G. Collet JP, et al. Among authors: silvain j. Circulation. 2008 Sep 16;118(12):1225-33. doi: 10.1161/CIRCULATIONAHA.108.776757. Epub 2008 Sep 2. Circulation. 2008. PMID: 18765393 Clinical Trial.
Can we override clopidogrel resistance?
Pena A, Collet JP, Hulot JS, Silvain J, Barthélémy O, Beygui F, Funck-Brentano C, Montalescot G. Pena A, et al. Among authors: silvain j. Circulation. 2009 Jun 2;119(21):2854-7. doi: 10.1161/CIRCULATIONAHA.108.857722. Circulation. 2009. PMID: 19487603 No abstract available.
Slow response to clopidogrel predicts low response.
Bellemain-Appaix A, Montalescot G, Silvain J, Barthélémy O, Beygui F, Collet JP, Sideris G, Meuleman C, Bal-Dit-Sollier C, Lellouche N, Ducrocq G, Slama M, Milleron O, Henry P, Drouet L; ALBION Investigators. Bellemain-Appaix A, et al. Among authors: silvain j. J Am Coll Cardiol. 2010 Feb 23;55(8):815-22. doi: 10.1016/j.jacc.2009.08.082. J Am Coll Cardiol. 2010. PMID: 20170822 Free article.
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.
Hulot JS, Collet JP, Silvain J, Pena A, Bellemain-Appaix A, Barthélémy O, Cayla G, Beygui F, Montalescot G. Hulot JS, et al. Among authors: silvain j. J Am Coll Cardiol. 2010 Jul 6;56(2):134-43. doi: 10.1016/j.jacc.2009.12.071. J Am Coll Cardiol. 2010. PMID: 20620727 Free article.
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.
Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E, Montalescot G. Beygui F, et al. Among authors: silvain j. Am J Cardiol. 2010 Sep 1;106(5):650-8. doi: 10.1016/j.amjcard.2010.04.019. Epub 2010 Jul 23. Am J Cardiol. 2010. PMID: 20723640 Clinical Trial.
269 results